APA (7th ed.) Citation

Abdelfattah, E. K., Hosny, S. M., Kassem, A. B., Moustafa, H. A. M., Tawfeik, A. M., Abdelhafez, M. N., . . . Salem, H. A. Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen. MDPI AG.

Chicago Style (17th ed.) Citation

Abdelfattah, Esraa K., et al. Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen. MDPI AG.

MLA (9th ed.) Citation

Abdelfattah, Esraa K., et al. Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen. MDPI AG.